United States

People: Ablynx NV (ABLX.BR)

ABLX.BR on Brussels Stock Exchange

20 Oct 2017
Change (% chg)

€0.25 (+1.58%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Simonsen, Kim 

Mr. Kim Simonsen is Chief Operations Officer of Ablynx NV. He received a Doctorate of Medicine degree from the University of Copenhagen and had clinical training for five years before moving into the pharmaceutical industry. He has experience within the field of particularly Clinical Drug Development in the European Union, the United States, Japan and China in different therapeutic areas. He has worked with Sandoz, Novo Nordisk, Novartis, Medicon (a CRO) and as Vice President for Global Clinical Development at ALK-Abello before moving to the Company. He has been given lectures in Clinical Pharmacology and Drug Development in Denmark, within the Association of the Pharmaceutical Industry in Denmark and at Copenhagen and Aalborg University.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --